BridgeMD
New treatment option for HIV Viremia
Official title PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY
ClinicalTrials.gov ID: NCT07021092
What this study is testing
- What it's testing
- The study aims to increase the reach of the person-centred interpersonal practices by developing and accessing a tailored, scalable, and sustainable approach that meets the distinctive needs of populations identified as most disproportionately affected by viremia in Zambia. The study population include pregnant and breastfeeding women, children, adolescents and adult that are more than thirty -30 days late for their next hospital appointments.The study will be implemented over a period of 36 months in 24 facilities in Lusaka and Central province, Zambia.
- Time commitment: about 36 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients that are lost to follow up ([LTFU] from HIV care i.e. confirmed \>30 days late for a scheduled appointment) at the time of sampling. (i.e...
- Individuals returning to care after being out of care and not taking ART with no VL measure (i.e., unmeasured viremia)
- Patients that are 6 months late for a scheduled Viral Load (VL) according to Ministry of Health guidelines at the time of sampling (regardless of...
- Patients that have a last documented VL that is elevated, \> 1000 copies/ml at time of sampling in current clinic population (CCP) (regardless of...
- Participant that are willing to provide written informed consent in English, or any of the local languages that include Nyanja or Bemba.
You likely can't join if
- Patients that are unable to provide consent or unwilling to participate in the study
- Participant who is NOT living with HIV/AIDS;
- Participant is too sick i.e., failing to talk, general discomfort and emergency cases);
The study team makes the final eligibility decision.
Where it's taking place
- Lusaka, Lusaka Province, Zambia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 36 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lusaka, Lusaka Province, Zambia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.